Location History:
- San Fermo Della Battaglia, IT (2019)
- Solbiate, IT (2018 - 2023)
Company Filing History:
Years Active: 2018-2023
Title: Terenzio Ignoni: Innovator in Pharmaceutical Methods
Introduction
Terenzio Ignoni is an inventor based in Italy, recognized for his contributions to the field of pharmaceutical sciences. His work primarily focuses on developing methods to assess the biological activity of defibrotide, a medication used in various therapeutic applications. Despite having no patents registered under his name, his innovative approaches have the potential to impact the pharmaceutical industry significantly.
Latest Patents
Ignoni's latest patents include two notable inventions related to defibrotide. The first is a "Cellular-Based Method For Determining The Potency Of Defibrotide." This invention outlines a cell-based approach to assess the biological activity of defibrotide by evaluating the viability of mammalian cells in the presence of cytotoxic agents and varying concentrations of defibrotide. This method is particularly valuable for standardizing pharmaceutical compositions containing defibrotide. The second patent is the "Euglobulin-Based Method For Determining The Biological Activity Of Defibrotide." This method involves bringing defibrotide into contact with mammalian euglobulin and a specific substrate for plasmin, allowing for the measurement of the product formed over time to determine the biological activity of defibrotide.
Career Highlights
Throughout his career, Ignoni has focused on innovative methods that enhance the understanding and application of pharmaceutical compounds. His research has contributed to the development of standardized formulations of defibrotide, which are crucial for ensuring consistent therapeutic outcomes.
Collaborations
Ignoni has collaborated with notable professionals in his field, including Vijay Kumar and Khalid Islam. These partnerships have facilitated the advancement of his research and the exploration of new methodologies in pharmaceutical sciences.
Conclusion
Terenzio Ignoni's work exemplifies the importance of innovation in the pharmaceutical industry. His methods for assessing the potency and biological activity of defibrotide are significant contributions that may lead to improved therapeutic applications.